We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
In This Issue of JAMA Dermatology |

Highlights FREE

JAMA Dermatol. 2013;149(11):1261. doi:10.1001/jamadermatol.2013.4093.
Text Size: A A A
Published online


Topical corticosteroids are the most frequently used drugs for treating skin conditions and are prescribed to more than 6% of pregnant women. The US Food and Drug Administration labels topical corticosteroids as pregnancy risk category C, meaning that animal studies have shown adverse fetal effects, but there are no adequate and well-controlled studies in pregnant women. In this retrospective cohort study, Chi et al reassuringly show no associations of maternal topical corticosteroid exposure with a comprehensive set of adverse fetal outcomes. The risk of low birth weight persists, especially with heavy maternal use of strong topical corticosteroids, and authors recommend keeping potent topical steroid use to a minimum and monitoring fetal growth if they are used.

The pathogenesis of acral melanoma remains unclear, although trauma has been suggested to be a predisposing factor. In this cross-sectional, retrospective study, Jung et al analyze the anatomic mapping and histopathologic features of acral melanomas and demonstrate that physical stress or pressure can influence the incidence and spreading pattern of these tumors. The long axis of spreading in plantar melanomas was typically along naturally occurring creases, which are the vectors that transmit the pressure strength when the soles contact a surface. Prospective studies of in situ lesions are necessary to better understand the spreading pattern.

Related Editorial

Cutaneous T-cell lymphoma (CTCL) refers to a group of lymphoproliferative disorders characterized by localization of T lymphocytes to the skin. A consistent increase in incidence of CTCL has been regularly documented since the early 1970s, which may be related to a real increase in cases along with an improvement in physician detection and diagnostic changes. In this population-based study designed to update our current understanding of CTCL epidemiology, Korgavkar et al demonstrate that the overall CTCL incidence has stabilized since 1998 and that 5-year CTCL survival rates increased until 2004.

Advancements in mobile technology, along with the ubiquitous adoption of the smartphone, have had a profound effect on the practice of medicine. Downloadable mobile applications (apps) have the ability to serve as diagnostic tools for physicians, educational resources for students, and health management programs for patients. In this study, Brewer et al identify and categorize the variety of current mobile apps available in dermatology for patients and providers. Although many apps had potential usefulness, the authors encourage users to recognize potential risks of using these as valid resources for dermatology information.

Tumor necrosis factor inhibitors have become important components in the treatment of multiple chronic inflammatory skin disorders. In this case report, Sand and Thomsen describe a patient with severe refractory acne conglobata that was unresponsive to doxycycline, isotretinoin, prednisolone, and dapsone. A sustained and marked reduction of symptoms was seen after 12 continuous months of adalimumab therapy, although the durability of this remission remains unknown.





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.